Rezolute (RZLT) Preferred Dividend Payments (2016 - 2019)

Rezolute (RZLT) posted Preferred Dividend Payments of $2.2 million for Q1 2019, down 62.24% sequentially from $5.9 million in Q2 2016.

Analysis

Rezolute (RZLT) Preferred Dividend Payments (2016 - 2019) Analysis & Trends

Rezolute has reported Preferred Dividend Payments for 2 years, with the latest figure at $2.2 million in Q1 2019.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $2.2 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $8.1 million (changed N/A YoY) and the FY2016 annual result came in at $6.0 million, changed N/A from the prior year.
Preferred Dividend Payments eased to $2.2 million in Q1 2019 per RZLT's latest filing, from $5.9 million in the prior quarter.
Over five years, Preferred Dividend Payments peaked at $5.9 million in Q2 2016 and troughed at $61279.0 in Q1 2016.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Vertex Pharmaceuticals	138.77 Bn	130.92 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.51 Bn	77.52 Bn	3.93 Bn	-
3	Argenx Se	63.51 Bn	58.32 Bn	1.37 Bn	-
4	Moderna	58.20 Bn	53.06 Bn	52.00 Mn	-
5	Revolution Medicines	44.04 Bn	44.04 Bn	-	-
6	BeOne Medicines	39.99 Bn	34.89 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.45 Bn	32.14 Bn	992.69 Mn	-
8	Royalty Pharma	28.40 Bn	27.56 Bn	-	-
9	Insmed	27.44 Bn	26.28 Bn	358.27 Mn	-
10	Rezolute	476.63 Mn	476.63 Mn	-	-

Historic Data

Download Data